Bumetanide – Maths Test ✔✔✔ Clinical trial ✖✖✖
Memantine, Arbaclofen and now Bumetanide stumble in clinical trials (also the less well known Balovaptan, which Roche dropped in 2020). Place your bets on Suramin, anyone? Plus ça change , plus c'est la même chose The more things change, the more they stay the same The first week of the school year brought two big surprises. Monty, aged 18 with autism, came top of the class in the math test. This is a big win for bumetanide treatment, because 9 years ago Monty was effectively innumerate. With a huge effort by his Assistant, he had learnt how to read and write, but even the most basic maths was beyond him. That all changed in 2012 thanks to Professor Ben-Ari’s published research on Bumetanide in autism. The sad news that week was that the Phase 3 clinical trial of Bumetanide for autism had been terminated early. Servier and Neurochlore announce the main results of the two phase 3 clinical studies assessing...